Home/ Supplements/ Electrolytes/ Mega Fat Burners

Mega Fat Burners

product on market Tablet or Pill ON Optimum Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 71% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile includes chromium and garcinia extract, which have limited to moderate evidence for supporting metabolic health and weight management. Choline and essential minerals like calcium and phosphorus provide basic nutritional support. Overall, the evidence coverage for these specific ingredients in a combined fat-burning context is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Mega Fat Burners
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
71%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
240 mg (24% DV)
185 mg (19% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:3)
400 mcg (333% DV)
11.4× RDA — above typical dose 199 studies (A:1, B:55)
Market median: 600.0mg (321 products) 5 studies — no high-quality reviews
400 mg
Within RDA (0.7× RDA) 38 studies (A:1, B:7)
200 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
100 mg
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)

Other Ingredients

Stearic Acid Croscarmellose Sodium Pharmaceutical Glaze Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Warnings & Precautions

WARNING: CONSULT YOUR PHYSICIAN BEFORE USING THIS PRODUCT IF YOU ARE TAKING ANY MEDICATIONS OR ARE UNDER A PHYSICIANS CARE FOR A MEDICAL CONDITION. NOT FOR USE BY THOSE UNDER THE AGE OF 18 OR WOMEN THAT ARE PREGNANT, TRYING TO GET PREGNANT, OR NURSING.

WARNING: CONSULT YOUR PHYSICIAN BEFORE USING THIS PRODUCT IF YOU ARE TAKING ANY MEDICATIONS OR ARE UNDER A PHYSICIANS CARE FOR A MEDICAL CONDITION. NOT FOR USE BY THOSE UNDER THE AGE OF 18 OR WOMEN THAT ARE PREGNANT, TRYING TO GET PREGNANT, OR NURSING.

Formulation Notes

STIMULANT FREE

Additional Information

FOR EXPORT ONLY

V.1.004.1114US 6031435

Metadata

Product Details

UPC / SKU7 48927 02004 5
DSLD Entry Date2016-03-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID57533
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.